244 related articles for article (PubMed ID: 17980943)
1. Critical assessment of the genetic toxicity of naphthalene.
Brusick D
Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S37-42. PubMed ID: 17980943
[TBL] [Abstract][Full Text] [Related]
2. Possible genotoxic modes of action for naphthalene.
Brusick D; Small MS; Cavalieri EL; Chakravarti D; Ding X; Longfellow DG; Nakamura J; Rogan EC; Swenberg JA
Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S43-50. PubMed ID: 18194829
[TBL] [Abstract][Full Text] [Related]
3. Genetic toxicity of naphthalene: a review.
Schreiner CA
J Toxicol Environ Health B Crit Rev; 2003; 6(2):161-83. PubMed ID: 12554433
[TBL] [Abstract][Full Text] [Related]
4. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
5. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
6. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
Cruzan G; Bus J; Banton M; Gingell R; Carlson G
Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
[TBL] [Abstract][Full Text] [Related]
7. A review of whole animal bioassays of the carcinogenic potential of naphthalene.
North DW; Abdo KM; Benson JM; Dahl AR; Morris JB; Renne R; Witschi H
Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S6-14. PubMed ID: 18364246
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the mode of action framework for mutagenic carcinogens case study II: chromium (VI).
McCarroll N; Keshava N; Chen J; Akerman G; Kligerman A; Rinde E
Environ Mol Mutagen; 2010 Mar; 51(2):89-111. PubMed ID: 19708067
[TBL] [Abstract][Full Text] [Related]
10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genotoxicity and the carcinogenic mode of action for ortho-phenylphenol.
Brusick D
Environ Mol Mutagen; 2005 Jun; 45(5):460-81. PubMed ID: 15714474
[TBL] [Abstract][Full Text] [Related]
12. Dose-response modeling of in vivo genotoxicity data for use in risk assessment: some approaches illustrated by an analysis of acrylamide.
Allen B; Zeiger E; Lawrence G; Friedman M; Shipp A
Regul Toxicol Pharmacol; 2005 Feb; 41(1):6-27. PubMed ID: 15649824
[TBL] [Abstract][Full Text] [Related]
13. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action.
Bogen KT; Benson JM; Yost GS; Morris JB; Dahl AR; Clewell HJ; Krishnan K; Omiecinski CJ
Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S27-36. PubMed ID: 18191315
[TBL] [Abstract][Full Text] [Related]
14. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
Bogen KT
Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
[TBL] [Abstract][Full Text] [Related]
15. A review of the mutagenicity and rodent carcinogenicity of ambient air.
Claxton LD; Woodall GM
Mutat Res; 2007; 636(1-3):36-94. PubMed ID: 17451995
[TBL] [Abstract][Full Text] [Related]
16. Exposure, epidemiology and human cancer incidence of naphthalene.
Griego FY; Bogen KT; Price PS; Weed DL
Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S22-6. PubMed ID: 18423820
[TBL] [Abstract][Full Text] [Related]
17. Benzothiazole toxicity assessment in support of synthetic turf field human health risk assessment.
Ginsberg G; Toal B; Kurland T
J Toxicol Environ Health A; 2011; 74(17):1175-83. PubMed ID: 21797770
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis-based weight of evidence: a tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action--naphthalene as an example.
Rhomberg LR; Bailey LA; Goodman JE
Crit Rev Toxicol; 2010 Sep; 40(8):671-96. PubMed ID: 20722583
[TBL] [Abstract][Full Text] [Related]
19. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
Gocke E; Bürgin H; Müller L; Pfister T
Toxicol Lett; 2009 Nov; 190(3):254-65. PubMed ID: 19857796
[TBL] [Abstract][Full Text] [Related]
20. Use of genetic toxicology information for risk assessment.
Dearfield KL; Moore MM
Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
